Massive liver cancer transplant registry aims to predict recurrence
NCT ID NCT06018857
First seen Mar 26, 2026 · Last updated May 02, 2026 · Updated 8 times
Summary
This study follows 1000 adults with liver cancer (hepatocellular carcinoma) who receive a liver transplant. Researchers will track how long patients stay cancer-free and how long they live overall. The goal is to find patterns that predict whether the cancer will come back after transplant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
Ohio State University
Columbus, Ohio, 43210, United States
Conditions
Explore the condition pages connected to this study.